/Investor DB

Longitude Capital — 2022 Investments

4 investments dated 2022 · listed companies and verified rows first · show all

Avenge Bioavengebio.comJan 2022 · $45M

Linklist is a link-in-bio tool that lets brands consolidate their links and products on a single page, including a digital catalog, URL shortener, and QR code generator.

E-commerceMarketing TechSaaS

Co-investorsPappas CapitalPerceptive Xontogeny VentureRock Springs Capital

IntelyCare, Inc.intelycare.comin𝕏Apr 2022 · $115M

IntelyCare operates a healthcare talent marketplace that connects nurses with care settings including hospitals, clinics, and other healthcare facilities.

B2B MarketplacesFuture of WorkHealthtechHR TechQuincy, US

Ike Nnah(Executive Officer, Director)inDavid Coppins(Executive Officer, Director)inPrince Nnah(Director)

Co-investorsEastward Capital PartnersEndeavour VisionEquitage Ventures, L.L.C.First Trust Capital PartnersGenerator VenturesKaiser Permanente Ventures+4 more

Limflowlimflow.comApr 2022 · $39M

LimFlow develops a medical device system for the treatment of chronic limb-threatening ischemia.

HealthtechMedical Devices

Co-investorsSofinnova Partners

Somatussomatus.cominFeb 2022 · $325M

Somatus provides value-based, integrated kidney care and a congestive heart failure management solution for patients, providers, and health plan partners.

Digital HealthHealthtechMclean, US

Ikenna Okezie(Executive Officer, Director)inAlexander Houlday(Executive Officer)inStacey Queen-Pyndell(Executive Officer)Larry Renfro(Interim President & CEO)

BoardAnna Haghgooie(Director)Anthony Welters(Director)

Co-investorsFlare Capital PartnersOptum VenturesHealthQuest CapitalBlue Venture FundsDefy PartnersRA Capital+7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.